Modified El-Ganzouri Risk Index for Predicting Difficult Intubation in Obese Patients (MEGRI)

October 2, 2026 updated by: Islam Ramzy Ahmed Ali, Zagazig University

A Trial to Modify the El-Ganzouri Risk Index by Incorporating Anthropometric Ratios for Predicting Difficult Intubation in Obese Patients Undergoing General Anesthesia

This observational study aims to compare the predictive performance of the Modified El-Ganzouri Risk Index (MEGRI) incorporating anthropometric ratios with the original El-Ganzouri Risk Index (EGRI) for predicting difficult intubation in obese adult patients undergoing elective general anesthesia.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

114

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Zagazig, Egypt
        • Zagazig University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Age: 21-65 years old.ASA: II,III.Obese patients (Body Mass Index (BMI) 30-40 kg/m² ) scheduled for elective surgical procedures under general anesthesia

Description

Inclusion Criteria:

  • Patient acceptance.
  • Age: 21-65 years old.
  • ASA: II,III.
  • Obese patients (Body Mass Index (BMI) 30-40 kg/m² ) scheduled for elective surgical procedures under general anesthesia

Exclusion Criteria:

  • Patients undergoing maxillofacial trauma surgery.
  • Patients with a history of neck surgery or cervical spine instability.
  • Pregnant patients, and those requiring rapid sequence intubation.
  • Upper airway pathology or surgery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: OTHER
  • Time Perspectives: CROSS_SECTIONAL

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Obese Adult Patients

Adult obese patients undergoing elective general anesthesia who will be assessed preoperatively using both the original El-Ganzouri Risk Index and the Modified El-Ganzouri Risk Index, followed by assessment of laryngoscopy and intubation outcomes.

This is an observational study. No study intervention is assigned. Patients receive standard anesthetic care, and preoperative airway assessment and intraoperative intubation outcomes are recorded for comparison of the original and Modified El-Ganzouri Risk Index.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Area Under the Receiver Operating Characteristic Curve (AUC) of the Modified El-Ganzouri Risk Index for Predicting Difficult Intubation
Time Frame: From preoperative airway assessment to completion of endotracheal intubation during surgery.

The predictive performance of the Modified El-Ganzouri Risk Index (MEGRI) for difficult intubation will be evaluated using receiver operating characteristic (ROC) curve analysis and the area under the curve (AUC).

From preoperative airway assessment to completion of endotracheal intubation during surgery.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Area Under the Receiver Operating Characteristic Curve (AUC) of the Original El-Ganzouri Risk Index for Predicting Difficult Intubation
Time Frame: From preoperative airway assessment to completion of endotracheal intubation during surgery.

The predictive performance of the original El-Ganzouri Risk Index (EGRI) for difficult intubation will be evaluated using receiver operating characteristic (ROC) curve analysis and the area under the curve (AUC).

From preoperative airway assessment to completion of endotracheal intubation during surgery.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intubation Difficulty Score (IDS)
Time Frame: During endotracheal intubation

The Intubation Difficulty Scale score will be recorded during tracheal intubation. An IDS score greater than 5 will indicate difficult intubation.

During endotracheal intubation
Sensitivity and Specificity of the Modified and Original El-Ganzouri Risk Indices for Predicting Difficult Intubation
Time Frame: From preoperative airway assessment to completion of endotracheal intubation during surgery

Difficult laryngoscopy will be defined as a Cormack-Lehane grade III or IV laryngeal view.

From preoperative airway assessment to completion of endotracheal intubation during surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2026

Primary Completion (Estimated)

March 31, 2027

Study Completion (Estimated)

March 31, 2027

Study Registration Dates

First Submitted

September 26, 2026

First Submitted That Met QC Criteria

October 2, 2026

First Posted (Actual)

October 5, 2026

Study Record Updates

Last Update Posted (Actual)

October 5, 2026

Last Update Submitted That Met QC Criteria

October 2, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe